nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PPARG—dermis—systemic scleroderma	0.0546	0.102	CbGeAlD
Icosapent—SLC8A1—smooth muscle tissue—systemic scleroderma	0.0264	0.0494	CbGeAlD
Icosapent—ACSL3—digestive system—systemic scleroderma	0.0252	0.047	CbGeAlD
Icosapent—PTGS2—skeletal joint—systemic scleroderma	0.0241	0.045	CbGeAlD
Icosapent—FABP7—connective tissue—systemic scleroderma	0.0212	0.0397	CbGeAlD
Icosapent—ACSL3—lung—systemic scleroderma	0.021	0.0393	CbGeAlD
Icosapent—SLC8A1—digestive system—systemic scleroderma	0.0209	0.039	CbGeAlD
Icosapent—PPARG—artery—systemic scleroderma	0.0197	0.0368	CbGeAlD
Icosapent—FADS1—smooth muscle tissue—systemic scleroderma	0.0176	0.0329	CbGeAlD
Icosapent—ACSL4—connective tissue—systemic scleroderma	0.0175	0.0327	CbGeAlD
Icosapent—Oropharyngeal pain—Pentoxifylline—systemic scleroderma	0.0169	0.0448	CcSEcCtD
Icosapent—PPARG—endothelium—systemic scleroderma	0.0167	0.0311	CbGeAlD
Icosapent—PPARG—blood vessel—systemic scleroderma	0.0154	0.0287	CbGeAlD
Icosapent—FABP7—digestive system—systemic scleroderma	0.0153	0.0287	CbGeAlD
Icosapent—Eructation—Pentoxifylline—systemic scleroderma	0.0151	0.0401	CcSEcCtD
Icosapent—TRPV1—digestive system—systemic scleroderma	0.0139	0.026	CbGeAlD
Icosapent—FADS1—tendon—systemic scleroderma	0.0133	0.0247	CbGeAlD
Icosapent—ACSL4—digestive system—systemic scleroderma	0.0126	0.0236	CbGeAlD
Icosapent—PPARD—digestive system—systemic scleroderma	0.0121	0.0227	CbGeAlD
Icosapent—ACSL4—tendon—systemic scleroderma	0.012	0.0225	CbGeAlD
Icosapent—FADS1—lung—systemic scleroderma	0.0116	0.0217	CbGeAlD
Icosapent—PPARD—tendon—systemic scleroderma	0.0116	0.0216	CbGeAlD
Icosapent—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.0109	0.624	CbGdCrCtD
Icosapent—ACSL4—lung—systemic scleroderma	0.0106	0.0197	CbGeAlD
Icosapent—Oropharyngeal pain—Leflunomide—systemic scleroderma	0.0106	0.028	CcSEcCtD
Icosapent—PTGS1—artery—systemic scleroderma	0.0105	0.0197	CbGeAlD
Icosapent—PPARD—lung—systemic scleroderma	0.0101	0.0189	CbGeAlD
Icosapent—PTGS2—artery—systemic scleroderma	0.0101	0.0188	CbGeAlD
Icosapent—Oropharyngeal pain—Mycophenolic acid—systemic scleroderma	0.0101	0.0267	CcSEcCtD
Icosapent—Oropharyngeal pain—Lisinopril—systemic scleroderma	0.00907	0.0241	CcSEcCtD
Icosapent—Eructation—Mycophenolic acid—systemic scleroderma	0.009	0.0239	CcSEcCtD
Icosapent—PTGS1—endothelium—systemic scleroderma	0.0089	0.0166	CbGeAlD
Icosapent—PTGS2—endothelium—systemic scleroderma	0.00851	0.0159	CbGeAlD
Icosapent—PTGS1—blood vessel—systemic scleroderma	0.00821	0.0153	CbGeAlD
Icosapent—PPARG—connective tissue—systemic scleroderma	0.00788	0.0147	CbGeAlD
Icosapent—PTGS2—blood vessel—systemic scleroderma	0.00785	0.0147	CbGeAlD
Icosapent—PPARG—smooth muscle tissue—systemic scleroderma	0.0072	0.0135	CbGeAlD
Icosapent—PPARG—skin of body—systemic scleroderma	0.00711	0.0133	CbGeAlD
Icosapent—Eructation—Mycophenolate mofetil—systemic scleroderma	0.0071	0.0188	CcSEcCtD
Icosapent—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00659	0.376	CbGdCrCtD
Icosapent—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00658	0.0175	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00599	0.0159	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00586	0.0156	CcSEcCtD
Icosapent—PPARG—digestive system—systemic scleroderma	0.00569	0.0106	CbGeAlD
Icosapent—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00548	0.0145	CcSEcCtD
Icosapent—PPARG—tendon—systemic scleroderma	0.00541	0.0101	CbGeAlD
Icosapent—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.005	0.0133	CcSEcCtD
Icosapent—Dysgeusia—Captopril—systemic scleroderma	0.00499	0.0132	CcSEcCtD
Icosapent—Arthralgia—Mometasone—systemic scleroderma	0.00494	0.0131	CcSEcCtD
Icosapent—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00483	0.0128	CcSEcCtD
Icosapent—PPARG—lung—systemic scleroderma	0.00475	0.00887	CbGeAlD
Icosapent—Anaphylactic shock—Mometasone—systemic scleroderma	0.00473	0.0125	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00472	0.0125	CcSEcCtD
Icosapent—Constipation—Pentoxifylline—systemic scleroderma	0.00469	0.0124	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00463	0.0123	CcSEcCtD
Icosapent—Arthralgia—Captopril—systemic scleroderma	0.00433	0.0115	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00431	0.0114	CcSEcCtD
Icosapent—PTGS1—connective tissue—systemic scleroderma	0.00421	0.00786	CbGeAlD
Icosapent—Malnutrition—Leflunomide—systemic scleroderma	0.0042	0.0111	CcSEcCtD
Icosapent—Dyspepsia—Mometasone—systemic scleroderma	0.00416	0.011	CcSEcCtD
Icosapent—Anaphylactic shock—Captopril—systemic scleroderma	0.00416	0.011	CcSEcCtD
Icosapent—Dysgeusia—Leflunomide—systemic scleroderma	0.00411	0.0109	CcSEcCtD
Icosapent—PTGS2—connective tissue—systemic scleroderma	0.00402	0.00752	CbGeAlD
Icosapent—Malnutrition—Mycophenolic acid—systemic scleroderma	0.004	0.0106	CcSEcCtD
Icosapent—Pruritus—Pentoxifylline—systemic scleroderma	0.00388	0.0103	CcSEcCtD
Icosapent—PTGS1—smooth muscle tissue—systemic scleroderma	0.00385	0.00719	CbGeAlD
Icosapent—PTGS1—skin of body—systemic scleroderma	0.0038	0.0071	CbGeAlD
Icosapent—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00379	0.01	CcSEcCtD
Icosapent—Arthralgia—Azathioprine—systemic scleroderma	0.00378	0.01	CcSEcCtD
Icosapent—PTGS2—smooth muscle tissue—systemic scleroderma	0.00368	0.00688	CbGeAlD
Icosapent—Dyspepsia—Captopril—systemic scleroderma	0.00366	0.0097	CcSEcCtD
Icosapent—PTGS2—skin of body—systemic scleroderma	0.00363	0.00679	CbGeAlD
Icosapent—Malnutrition—Lisinopril—systemic scleroderma	0.00361	0.00956	CcSEcCtD
Icosapent—Arthralgia—Leflunomide—systemic scleroderma	0.00357	0.00948	CcSEcCtD
Icosapent—Constipation—Captopril—systemic scleroderma	0.00355	0.00943	CcSEcCtD
Icosapent—Dysgeusia—Lisinopril—systemic scleroderma	0.00353	0.00937	CcSEcCtD
Icosapent—Vomiting—Pentoxifylline—systemic scleroderma	0.00349	0.00925	CcSEcCtD
Icosapent—Rash—Pentoxifylline—systemic scleroderma	0.00346	0.00917	CcSEcCtD
Icosapent—Dermatitis—Pentoxifylline—systemic scleroderma	0.00345	0.00916	CcSEcCtD
Icosapent—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00342	0.00908	CcSEcCtD
Icosapent—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00341	0.00904	CcSEcCtD
Icosapent—Pruritus—Mometasone—systemic scleroderma	0.00335	0.00888	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.0033	0.00876	CcSEcCtD
Icosapent—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00838	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00314	0.00832	CcSEcCtD
Icosapent—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00313	0.00831	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00312	0.00828	CcSEcCtD
Icosapent—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00821	CcSEcCtD
Icosapent—Arthralgia—Lisinopril—systemic scleroderma	0.00307	0.00814	CcSEcCtD
Icosapent—PTGS1—digestive system—systemic scleroderma	0.00304	0.00568	CbGeAlD
Icosapent—Dyspepsia—Leflunomide—systemic scleroderma	0.00301	0.008	CcSEcCtD
Icosapent—Vomiting—Mometasone—systemic scleroderma	0.00301	0.00798	CcSEcCtD
Icosapent—Rash—Mometasone—systemic scleroderma	0.00298	0.00791	CcSEcCtD
Icosapent—Dermatitis—Mometasone—systemic scleroderma	0.00298	0.00791	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00298	0.0079	CcSEcCtD
Icosapent—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00296	0.00784	CcSEcCtD
Icosapent—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00294	0.00781	CcSEcCtD
Icosapent—Pruritus—Captopril—systemic scleroderma	0.00294	0.0078	CcSEcCtD
Icosapent—Constipation—Leflunomide—systemic scleroderma	0.00293	0.00777	CcSEcCtD
Icosapent—PTGS2—digestive system—systemic scleroderma	0.00291	0.00543	CbGeAlD
Icosapent—PTGS1—tendon—systemic scleroderma	0.00289	0.0054	CbGeAlD
Icosapent—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00288	0.00763	CcSEcCtD
Icosapent—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00282	0.00748	CcSEcCtD
Icosapent—FFAR1—Peptide hormone metabolism—ACE—systemic scleroderma	0.00281	0.0401	CbGpPWpGaD
Icosapent—Constipation—Mycophenolic acid—systemic scleroderma	0.00279	0.00741	CcSEcCtD
Icosapent—PTGS2—tendon—systemic scleroderma	0.00277	0.00517	CbGeAlD
Icosapent—FADS1—PPARA activates gene expression—CTGF—systemic scleroderma	0.0027	0.0386	CbGpPWpGaD
Icosapent—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00269	0.00713	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00268	0.00711	CcSEcCtD
Icosapent—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.00264	0.0377	CbGpPWpGaD
Icosapent—Vomiting—Captopril—systemic scleroderma	0.00264	0.00701	CcSEcCtD
Icosapent—Rash—Captopril—systemic scleroderma	0.00262	0.00695	CcSEcCtD
Icosapent—Dermatitis—Captopril—systemic scleroderma	0.00262	0.00694	CcSEcCtD
Icosapent—Dyspepsia—Lisinopril—systemic scleroderma	0.00259	0.00687	CcSEcCtD
Icosapent—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00684	CcSEcCtD
Icosapent—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00254	0.00674	CcSEcCtD
Icosapent—PTGS1—lung—systemic scleroderma	0.00254	0.00474	CbGeAlD
Icosapent—Constipation—Lisinopril—systemic scleroderma	0.00252	0.00668	CcSEcCtD
Icosapent—PTGS2—lung—systemic scleroderma	0.00243	0.00453	CbGeAlD
Icosapent—Pruritus—Leflunomide—systemic scleroderma	0.00242	0.00643	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00623	CcSEcCtD
Icosapent—Pruritus—Mycophenolic acid—systemic scleroderma	0.00231	0.00613	CcSEcCtD
Icosapent—Vomiting—Azathioprine—systemic scleroderma	0.00231	0.00612	CcSEcCtD
Icosapent—Rash—Azathioprine—systemic scleroderma	0.00229	0.00607	CcSEcCtD
Icosapent—Dermatitis—Azathioprine—systemic scleroderma	0.00228	0.00606	CcSEcCtD
Icosapent—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00602	CcSEcCtD
Icosapent—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00223	0.0059	CcSEcCtD
Icosapent—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00585	CcSEcCtD
Icosapent—Vomiting—Leflunomide—systemic scleroderma	0.00218	0.00578	CcSEcCtD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00217	0.031	CbGpPWpGaD
Icosapent—Rash—Leflunomide—systemic scleroderma	0.00216	0.00573	CcSEcCtD
Icosapent—Dermatitis—Leflunomide—systemic scleroderma	0.00216	0.00572	CcSEcCtD
Icosapent—Malnutrition—Prednisone—systemic scleroderma	0.00214	0.00568	CcSEcCtD
Icosapent—Pruritus—Lisinopril—systemic scleroderma	0.00208	0.00552	CcSEcCtD
Icosapent—Vomiting—Mycophenolic acid—systemic scleroderma	0.00208	0.00551	CcSEcCtD
Icosapent—Rash—Mycophenolic acid—systemic scleroderma	0.00206	0.00546	CcSEcCtD
Icosapent—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00206	0.00546	CcSEcCtD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—SMAD7—systemic scleroderma	0.00195	0.0278	CbGpPWpGaD
Icosapent—Vomiting—Lisinopril—systemic scleroderma	0.00187	0.00496	CcSEcCtD
Icosapent—Rash—Lisinopril—systemic scleroderma	0.00186	0.00492	CcSEcCtD
Icosapent—Dermatitis—Lisinopril—systemic scleroderma	0.00185	0.00492	CcSEcCtD
Icosapent—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00484	CcSEcCtD
Icosapent—Arthralgia—Prednisone—systemic scleroderma	0.00182	0.00484	CcSEcCtD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00182	0.026	CbGpPWpGaD
Icosapent—Malnutrition—Methotrexate—systemic scleroderma	0.00179	0.00475	CcSEcCtD
Icosapent—Dysgeusia—Methotrexate—systemic scleroderma	0.00175	0.00465	CcSEcCtD
Icosapent—Anaphylactic shock—Prednisone—systemic scleroderma	0.00175	0.00464	CcSEcCtD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00165	0.0235	CbGpPWpGaD
Icosapent—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00435	CcSEcCtD
Icosapent—Rash—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00431	CcSEcCtD
Icosapent—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00431	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00159	0.00422	CcSEcCtD
Icosapent—Dyspepsia—Prednisone—systemic scleroderma	0.00154	0.00408	CcSEcCtD
Icosapent—Arthralgia—Methotrexate—systemic scleroderma	0.00152	0.00404	CcSEcCtD
Icosapent—Constipation—Prednisone—systemic scleroderma	0.00149	0.00396	CcSEcCtD
Icosapent—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00146	0.00387	CcSEcCtD
Icosapent—PTGS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.00136	0.0194	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00133	0.00353	CcSEcCtD
Icosapent—SLC8A1—Platelet homeostasis—NOS3—systemic scleroderma	0.00129	0.0184	CbGpPWpGaD
Icosapent—Dyspepsia—Methotrexate—systemic scleroderma	0.00129	0.00341	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.00128	0.0183	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00126	0.00335	CcSEcCtD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.00125	0.0179	CbGpPWpGaD
Icosapent—Pruritus—Prednisone—systemic scleroderma	0.00124	0.00328	CcSEcCtD
Icosapent—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.00117	0.0167	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00114	0.0163	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—EDN1—systemic scleroderma	0.00114	0.0163	CbGpPWpGaD
Icosapent—Vomiting—Prednisone—systemic scleroderma	0.00111	0.00295	CcSEcCtD
Icosapent—Rash—Prednisone—systemic scleroderma	0.0011	0.00292	CcSEcCtD
Icosapent—Dermatitis—Prednisone—systemic scleroderma	0.0011	0.00292	CcSEcCtD
Icosapent—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.00106	0.0151	CbGpPWpGaD
Icosapent—Pruritus—Methotrexate—systemic scleroderma	0.00103	0.00274	CcSEcCtD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.00102	0.0146	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—SELP—systemic scleroderma	0.000996	0.0142	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000994	0.0142	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000957	0.0137	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TOP1—systemic scleroderma	0.000939	0.0134	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—RHOB—systemic scleroderma	0.00093	0.0133	CbGpPWpGaD
Icosapent—Vomiting—Methotrexate—systemic scleroderma	0.000929	0.00246	CcSEcCtD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000925	0.0132	CbGpPWpGaD
Icosapent—Rash—Methotrexate—systemic scleroderma	0.000921	0.00244	CcSEcCtD
Icosapent—Dermatitis—Methotrexate—systemic scleroderma	0.00092	0.00244	CcSEcCtD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000865	0.0124	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000865	0.0124	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.000855	0.0122	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—CSK—systemic scleroderma	0.000847	0.0121	CbGpPWpGaD
Icosapent—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000842	0.012	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—ITGAM—systemic scleroderma	0.000796	0.0114	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000793	0.0113	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000756	0.0108	CbGpPWpGaD
Icosapent—PPARG—PPARA activates gene expression—CTGF—systemic scleroderma	0.000749	0.0107	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000745	0.0106	CbGpPWpGaD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000733	0.0105	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000725	0.0104	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000711	0.0102	CbGpPWpGaD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.000684	0.00977	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.000682	0.00974	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000662	0.00946	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000656	0.00937	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—RHOB—systemic scleroderma	0.000637	0.0091	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000634	0.00906	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.00059	0.00843	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—RHOB—systemic scleroderma	0.000578	0.00826	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—EDN1—systemic scleroderma	0.000575	0.00822	CbGpPWpGaD
Icosapent—PPARD—Ectoderm Differentiation—CCL2—systemic scleroderma	0.000559	0.00798	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000553	0.0079	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000551	0.00787	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000544	0.00777	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—ACE—systemic scleroderma	0.00053	0.00757	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000517	0.00738	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—HSPG2—systemic scleroderma	0.000508	0.00726	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000505	0.00722	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000486	0.00695	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SMAD7—systemic scleroderma	0.000442	0.00631	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000438	0.00626	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000433	0.00618	CbGpPWpGaD
Icosapent—FADS1—Metabolism—HSPG2—systemic scleroderma	0.000426	0.00609	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—MMP1—systemic scleroderma	0.000399	0.0057	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCL2—systemic scleroderma	0.000393	0.00562	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—HSPG2—systemic scleroderma	0.000385	0.0055	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CTGF—systemic scleroderma	0.000385	0.0055	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—HSPG2—systemic scleroderma	0.000385	0.0055	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—SMAD7—systemic scleroderma	0.000382	0.00545	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000369	0.00526	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—TNFSF13—systemic scleroderma	0.000355	0.00507	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—TGFB1—systemic scleroderma	0.000346	0.00494	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RHOB—systemic scleroderma	0.000342	0.00488	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—MMP1—systemic scleroderma	0.00034	0.00486	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—EDN1—systemic scleroderma	0.000325	0.00464	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CTGF—systemic scleroderma	0.000323	0.00461	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HSPG2—systemic scleroderma	0.000322	0.0046	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—RHOB—systemic scleroderma	0.000315	0.0045	CbGpPWpGaD
Icosapent—PPARD—NRF2 pathway—TGFB1—systemic scleroderma	0.000315	0.0045	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CSK—systemic scleroderma	0.000311	0.00444	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000306	0.00438	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—EDN1—systemic scleroderma	0.000295	0.00422	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CTGF—systemic scleroderma	0.000292	0.00417	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CTGF—systemic scleroderma	0.000292	0.00417	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—NOS3—systemic scleroderma	0.000289	0.00413	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000287	0.0041	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	0.00028	0.004	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CCL2—systemic scleroderma	0.000277	0.00395	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000266	0.00379	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—MMP2—systemic scleroderma	0.000263	0.00376	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000243	0.00347	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000239	0.00342	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000232	0.00332	CbGpPWpGaD
Icosapent—PPARD—Metabolism—HSPG2—systemic scleroderma	0.000217	0.00309	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—CTGF—systemic scleroderma	0.000211	0.00301	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SMAD7—systemic scleroderma	0.000208	0.00298	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL2—systemic scleroderma	0.000202	0.00288	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000201	0.00287	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—TNFSF13—systemic scleroderma	0.000194	0.00277	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	0.000192	0.00275	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TGFB1—systemic scleroderma	0.000191	0.00273	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—TGFB1—systemic scleroderma	0.000189	0.00269	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000186	0.00266	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000185	0.00264	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EDN1—systemic scleroderma	0.000174	0.00249	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—NOS3—systemic scleroderma	0.000168	0.0024	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CTGF—systemic scleroderma	0.000164	0.00234	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000148	0.00211	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	0.000146	0.00208	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000141	0.00201	CbGpPWpGaD
Icosapent—FADS1—Metabolism—NOS3—systemic scleroderma	0.000141	0.00201	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	0.000138	0.00196	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—NOS3—systemic scleroderma	0.000127	0.00182	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—NOS3—systemic scleroderma	0.000127	0.00182	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL2—systemic scleroderma	0.000119	0.0017	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HSPG2—systemic scleroderma	0.000118	0.00169	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CTGF—systemic scleroderma	0.000115	0.00165	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000113	0.00162	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000112	0.0016	CbGpPWpGaD
Icosapent—PTGS2—Disease—SMAD7—systemic scleroderma	0.000108	0.00154	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NOS3—systemic scleroderma	0.000106	0.00152	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP2—systemic scleroderma	0.000105	0.0015	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFBI—systemic scleroderma	9.84e-05	0.00141	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CTGF—systemic scleroderma	8.96e-05	0.00128	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—systemic scleroderma	8.53e-05	0.00122	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HSPG2—systemic scleroderma	8.28e-05	0.00118	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—systemic scleroderma	7.87e-05	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Disease—HSPG2—systemic scleroderma	7.85e-05	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	7.71e-05	0.0011	CbGpPWpGaD
Icosapent—PTGS2—Disease—CSK—systemic scleroderma	7.58e-05	0.00108	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NOS3—systemic scleroderma	7.14e-05	0.00102	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD247—systemic scleroderma	7.13e-05	0.00102	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TGFB1—systemic scleroderma	7.03e-05	0.001	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSPG2—systemic scleroderma	6.58e-05	0.000939	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TGFB1—systemic scleroderma	6.49e-05	0.000926	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CTGF—systemic scleroderma	6.28e-05	0.000897	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CTGF—systemic scleroderma	4.98e-05	0.000712	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NOS3—systemic scleroderma	3.9e-05	0.000557	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NOS3—systemic scleroderma	2.73e-05	0.00039	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS3—systemic scleroderma	2.59e-05	0.00037	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NOS3—systemic scleroderma	2.17e-05	0.00031	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFB1—systemic scleroderma	1.71e-05	0.000245	CbGpPWpGaD
